Parkway Life REIT
SGX: C2PU
4.010
+0.50%
Share Price in SGD. As of 30 Sep 17:04:44 SGT
Make Beansprout your preferred source on Google
Add us on Google to see more of our insights in your search results
Price chart
Key Stats
Share Price Target
Beansprout Analysis
Compare REITs
Have another REIT in mind?
Select a REIT to compare with Parkway Life REIT
Market Analysis
Analyst Ratings
Beansprout
05 May 2026
BUY
SGD 4.600
DBS
13 Jul 2026
BUY
SGD 4.750
DBS Research
13 Jul 2026
BUY
SGD 4.750
Maybank Research
08 Apr 2026
BUY
SGD 4.880
OCBC Research
16 Jul 2026
BUY
SGD 4.800
UOB Kay Hian
13 May 2026
BUY
SGD 5.450
Opportunity Screen
Valuation
Financials
News
Announcements
Profile
CEO
-
IPO Date
-
Headquarters
-
Exchange
SGX
Sector
-
Industry
-
Employees
-
Website
-
Company description
Parkway Life REIT invests in healthcare and healthcare-related real estate in Asia-Pacific. Its portfolio includes private hospitals in Singapore and healthcare-related assets such as nursing homes and aged-care facilities in Japan and Malaysia. Revenue is generated mainly from long-term leases and rental income from healthcare operators. The REIT sits in the healthcare infrastructure value chain by owning specialised real estate used to deliver medical, hospital and eldercare services. Parkway Life REIT was listed on the SGX-ST in 2007 and is managed by Parkway Trust Management Limited.
Discussion
0 comments